Antidotes Market – Global Industry Analysis by Type, Route of Administration, Application, Region and Forecast (2022-2029)

Antidotes Market is anticipated to reach US$ 3.07 Bn. by 2029 from US$ 1.59 Bn. in 2021 at a CAGR of 8.5 % during a forecast period.

An antidote is a pharmacological or toxicological medicine that is used to counteract the poisonous effects of a toxin. Antidotes work by either changing the chemical composition of the toxin or interfering with the poison's attachment to biological locations.
Antidotes Market Dynamics:
Antidotes have been used since the dawn of medicine. An antidote is a substance that counteracts the effects of a poison or an overdose of another medication. It aids in the neutralization of the harmful effects of a toxin in the body and contains scientific methodologies that have been used to evaluate the therapeutic use of antidotes. The most significant developments include the use of antidotes in the management of poisoning cases that have occurred in recent years.To know about the Research Methodology:- Request Free Sample Report

The market is largely driven by the occurrence of snake bites and the adverse effects associated with them. According to the WHO, around 4.5–5.4 million people are bitten by snakes each year, 1.8–2.7 million of them suffer clinical sickness (envenoming) as a result of the bite, and the death toll might vary from 81,000 to 138,000. This is the primary element driving the growth of the antidotes market. In addition, the increasing occurrence of drug overdose fuels the demand for antidotes. Paracetamol poisoning is the most frequent drug overdose, which can cause liver damage and failure.

In addition, the global antidotes market is expected to be driven by increased awareness and research on the identification of toxins of venomous bites by firms and governments to grow to understand antidotes and pharmaceuticals. Antidote demand is being driven by an increase in the occurrence of medical diseases linked to antidotes, such as trichotillomania, toxoplasmosis prophylaxis, smoking cessation, and reversal of sedation, reversal of opioid sedation, pneumocystis pneumonia prophylaxis, and opioid overdose.

However, several restrictions in the antidote market, such as the low supply of anti-venoms owing to rising anti-venom costs restricted demand, resulting in treatment declining drastically or even disappearing in some places, are expected to hinder the antidote market’s growth.
Antidotes Market Segmentation Analysis
By Type, Chemical antidotes are the most often used drugs. They exactly engage with and neutralize the poison. Chemical antidotes function by either producing a chemical or converting metabolism. Naloxone hydrochloride is the most often used pharmaceutical antidote for opioid overdose.

By Application, Heavy metal toxicity accounts for a significant portion of the market. The key drivers of category expansion include the increased use of herbal treatments containing heavy metals, as well as rising water contamination. Poisoning with heavy metals is exceedingly dangerous to one's health. Anemia, miscarriages, and early labor are the most prevalent symptoms of heavy metal poisoning. Chelation, or the use of chemical antidotes, is an important part of treatment. Anemia affects 1.62 billion people (95 percent confidence interval: 1.50–1.74 billion), or 24.8 percent of the world's population. As a result, these factors have a function in segment growth.
Antidotes Market Regional Insight
Because of the high incidence of anemia and ongoing research and development initiatives, North America is expected to see revenue growth over the forecast period. Anti-venom manufacturing capacity and awareness of clinical aspects of envenoming, as well as other factors such as higher healthcare spending and improved medical facilities, are driving market growth in the region. Due to technical advances in antidotes, Europe held the second biggest market share in 2021.

Due to a growth in the occurrence of medical disorders linked with antidotes such as nerve agent poisoning, methotrexate rescue, methanol poisoning, mercury poisoning, lead poisoning, and gold poisoning, the APAC market is expected to grow at a quick rate. The region's high population density and intensive agricultural operations are also forecast to expand demand for the antidote.

The antidote market is dominated by MEA, followed by the Asia Pacific, because of the increasing number of cases detected in these areas. According to the World Health Organization, over 1 million snake bites occur in Africa each year, resulting in 50,000 people needing medical attention, 25,000 fatalities, and another 25,000 people with lasting impairments. The Asia Pacific market is expected to grow rapidly during the forecast period because of an increase in the occurrence of medical problems related to antidotes such as nerve agent poisoning, methotrexate rescue, methanol poisoning, mercury poisoning, lead poisoning, and gold poisoning.

These figures are unknown due to a lack of a reliable reporting system in these areas and a failure to report injuries to health care institutions. Due to the high population density and large agricultural operations in the Asia Pacific region, the antidote market is expected to grow significantly throughout the forecast period, boosting demand for antidotes. However, market growth in other regions, such as Latin America, has been disappointing due to a lack of effective snakebite control programs and snakebite management.
Report Objectives:
• Landscape analysis of the Antidotes Market

• competitive benchmarking

• Past and current status of the industry with the forecasted market size and trends

• Evaluation of potential key players that include market leaders, followers, and new entrants

• Technology trends

• Potential impact of micro-economic factors of the market

• External and Internal factors affecting market have been analysed

The report also helps in understanding the Antidotes Market dynamics, structure by analysing the market segments and project the Antidotes Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Antidotes Market make the report investor’s guide.
Antidotes Market Scope: Inquire before buying



Global Antidotes Market


Report Coverage
Details


Base Year:
2021
Forecast Period:
2022-2029


Historical Data:
2017 to 2021
Market Size in 2021:
US $ 1.59 Bn.


Forecast Period 2022 to 2029 CAGR:
8.5%
Market Size in 2029:
US $ 3.07 Bn.


 Segments Covered:
by Type
• Chemical Antidotes
• Pharmacological Antidotes
• Others


by Route of Administration
• Injectable
• Oral
o Capsules/Tablets
o Syrup


by Application
• Animal Bites
• Heavy Metal Poisoning



Antidotes Market, by Region
• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)
Antidotes Market Key Players
• Pfizer Inc.
• Hikma Pharmaceuticals PLC
• Dr. Reddy’s Laboratories Ltd
• Aurobindo Pharma
• Endo International Inc.
• Mylan N.V.
• Akorn Incorparated
• Alvogen
• Fresenius Kabi AG
• Zydus Cadila
• Daiichi Sanko Inc.
• Nichi-Iko Pharmaceutical Co., Ltd
• ADAPT Pharma, Inc.
• Baxter International, Inc.
• Meridian Medical Technologies, Inc.
• Novartis AG
• Spectrum Pharmaceuticals, Inc.
Frequently Asked Questions
1. What is the projected market size & growth rate of Antidotes Market?
Ans- Antidotes Market was valued at USD 1.59 Bn in 2021 and is projected to reach USD 3.07 Bn by 2029, growing at a CAGR of 8.5 % during the forecast period.

2. What is the key driving factor for the growth of Antidotes Market?
Ans- The market is largely driven by the occurrence of snake bites and the adverse effects associated with them.

3. Which Region accounted for the largest Antidotes Market share?
Ans- Because of the high incidence of anemia and ongoing research and development initiatives, North America is expected to see revenue growth over the forecast period.

4. What makes North America a Lucrative Market for Antidotes Market?
Ans- Anti-venom manufacturing capacity and awareness of clinical aspects of envenoming, as well as other factors such as higher healthcare spending and improved medical facilities, are driving market growth in the region.

5. What are the top players operating in Antidotes Market?
Ans- Pfizer Inc., Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Aurobindo Pharma, Endo International Inc., and Mylan N.V.